这是一篇关于应用安妥明(Clofibrate)治疗由于脑动脉粥样硬化引起的脑梗塞或短暂性脑缺血发作(TIA)的病死率和后遗症的总结,系由20个有经验的医院共同合作研究的成果。先后总共观察了532名患者,追随了4年半时间。治疗方法是每日给安妥明2克,治疗前和定期测定其血中胆固醇及三酸甘油脂水平。 This is a summary of the mortality and sequelae of Clofibrate in the treatment of cerebral infarction or transient ischemic attack (TIA) due to cerebral atherosclerosis and is co-authored by 20 experienced hospitals The research results. A total of 532 patients were observed, followed by 4 and a half years. Treatment is daily to clofibrate 2 grams, before treatment and regular determination of blood cholesterol and triglyceride levels.